Clinical Trial: A Trial of Inebilizumab in Participants With Autoimmune Hepatitis

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598825) titled 'A Trial of Inebilizumab in Participants With Autoimmune Hepatitis' on May 14.

Brief Summary: The main objectives of this trial are to evaluate the safety and tolerability of inebilizumab in participants with autoimmune hepatitis (AIH) (Part 1) and to evaluate the efficacy of inebilizumab on AIH disease activity and glucocorticoid (GC) use in the management of AIH (Part 2).

Study Start Date: Sept. 07, 2026

Study Type: INTERVENTIONAL

Condition: Autoimmune Hepatitis AIH

Intervention: DRUG: Inebilizumab

Inebilizumab will be administered as an IV infusion.

DRUG: Placebo

Placebo will be administered as IV infusion.

OTHER: Standar...